Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Nick Andrews

    Audio

    Most patients with nonmetastatic tracheal cancer did not undergo resection

    Author:
    Nick Andrews
    Publish date: October 30, 2019

    SAN FRANCISCO – Is surgery underutilized for patients with resectable tracheal cancer?

    • Read More

    Audio

    ECMO: Age did not predict mortality for trauma patients

    Author:
    Nick Andrews
    Publish date: October 29, 2019

    SAN FRANCISCO – Age of 65 years or older was not a predictive factor for mortality for patients who received ECMO for trauma-related ARDS.

    • Read More

    News

    Psoriatic arthritis patients’ cardiovascular risks aren’t spurring increased management

    Author:
    Nick Andrews
    Publish date: May 23, 2018

    Patients with PsA have a higher risk for cardiovascular morbidity but are managed with the same intensity as the general population.

    • Read More

    News

    Physical therapy, exercise still relevant for ankylosing spondylitis

    Author:
    Nick Andrews
    Publish date: May 22, 2018

    CAMBRIDGE, MASS.

    • Read More

    News

    Family history of psoriasis and PsA predicts disease phenotype

    Author:
    Nick Andrews
    Publish date: May 5, 2018

    Some rheumatologic family history may predict disease phenotype for psoriasis and psoriatic arthritis.

    • Read More

    News

    PPI use not linked to cognitive decline

    Author:
    Nick Andrews
    Publish date: May 1, 2018

    Prospective studies found no link between cognitive decline and use of proton pump inhibitors.

    • Read More

    News

    Novel oral immunotherapy increased peanut tolerance in children, adults

    Author:
    Nick Andrews
    Publish date: March 21, 2018

    ORLANDO – For children with peanut allergy, a therapy is on the horizon that could bring increased tolerance.

    • Read More

    News

    Omalizumab may help with chemotherapy hypersensitivity

    Author:
    Nick Andrews
    Publish date: March 21, 2018

    ORLANDO – “In a small minority of patents, no matter what we try, we simply cannot desensitize them – those are the patients we looked at in this...

    • Read More

    News

    Switch to mepolizumab safe in eosinophilic asthma

    Author:
    Nick Andrews
    Publish date: March 18, 2018

    ORLANDO – For patients with severe eosinophilic asthma who do not show improvement with omalizumab, a switch to mepolizumab could be a safe and...

    • Read More

    News

    Olopatadine/mometasone combo is safe and effective

    Author:
    Nick Andrews
    Publish date: March 14, 2018

    ORLANDO – Combining two safe and effective options for seasonal allergic rhinitis showed even more efficacy with relative safety.

    • Read More

    News

    TFR achievable with second-line nilotinib for chronic CML

    Author:
    Nick Andrews
    Publish date: March 9, 2018

    The phase 2 study showed high rates of treatment-free remission in patients who achieved a sustained molecular response.

    • Read More

    News

    NIAID proposes 3-pronged plan for universal influenza vaccine

    Author:
    Nick Andrews
    Publish date: February 28, 2018

    Three-pronged NIAID plan will focus on research needed to develop a universal influenza vaccine.

    • Read More

    News

    Women aged 35-39 years at greater risk for stillbirth

    Author:
    Nick Andrews
    Publish date: February 24, 2018

    Researchers in Denmark analyzed a large number of first-trimester pregnancies to make risk estimates for adverse outcomes.

    • Read More

    News

    FIRST trial analysis shows more benefit for lenalidomide

    Author:
    Nick Andrews
    Publish date: February 12, 2018

    The FIRST trial evaluates treatment options for patients with newly-diagnosed multiple myeloma who are not eligible for transplant.

    • Read More

    News

    Two biomarkers predict immunotherapy response for NSCLC

    Author:
    Nick Andrews
    Publish date: February 6, 2018

    Two biomarkers were associated with poor outcomes for patients with non–small cell lung cancer who were treated with immune checkpoint inhibitors...

    • Read More

    Pages

    • 1
    • 2
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery